Inhibition of glucagon-mediated increases in hepatic cyclic adenosine 3', 5'-monophosphate by prostaglandin E1 and E2.
D000262:Adenylyl Cyclases / Q000378:metabolism; D000818:Animals; D000242:Cyclic AMP / Q000378:metabolism*; D005934:Glucagon / Q000037:antagonists & inhibitors* / Q000494:pharmacology; D006006:Glycogen Synthase / Q000378:metabolism; D007328:Insulin / Q000494:pharmacology; D008099:Liver / Q000201:enzymology / Q000378:metabolism*; D008297:Male; D010727:Phosphoric Diester Hydrolases / Q000378:metabolism; D011453:Prostaglandins / Q000008:administration & dosage / Q000494:pharmacology*
D007328:Insulin; D011453:Prostaglandins; D005934:Glucagon; D000242:Cyclic AMP; D006006:Glycogen Synthase; D010727:Phosphoric Diester Hydrolases; D000262:Adenylyl Cyclases